Cite
OP12.08: Clinical implementation of the sFlt-1/ PlGF ratio at 24-28 weeks' gestation to detect pre-eclampsia among high-risk women selected by risk factors and uterine artery Doppler.
MLA
Herraiz, I., et al. “OP12.08: Clinical Implementation of the SFlt-1/ PlGF Ratio at 24-28 Weeks’ Gestation to Detect Pre-Eclampsia among High-Risk Women Selected by Risk Factors and Uterine Artery Doppler.” Ultrasound in Obstetrics & Gynecology, vol. 48, Sept. 2016, pp. 87–88. EBSCOhost, https://doi.org/10.1002/uog.16269.
APA
Herraiz, I., Gómez-Arriaga, P. I., Simón, E., García-Burguillo, A., López-Jiménez, E. A., Quezada, M. S., & Galindo, A. (2016). OP12.08: Clinical implementation of the sFlt-1/ PlGF ratio at 24-28 weeks’ gestation to detect pre-eclampsia among high-risk women selected by risk factors and uterine artery Doppler. Ultrasound in Obstetrics & Gynecology, 48, 87–88. https://doi.org/10.1002/uog.16269
Chicago
Herraiz, I., P.I. Gómez-Arriaga, E. Simón, A. García-Burguillo, E.A. López-Jiménez, M.S. Quezada, and A. Galindo. 2016. “OP12.08: Clinical Implementation of the SFlt-1/ PlGF Ratio at 24-28 Weeks’ Gestation to Detect Pre-Eclampsia among High-Risk Women Selected by Risk Factors and Uterine Artery Doppler.” Ultrasound in Obstetrics & Gynecology 48 (September): 87–88. doi:10.1002/uog.16269.